Risk factors for mortality in ICU patients with Acinetobacter baumannii ventilator-associated pneumonia: impact of bacterial cytotoxicity.

Background Acinetobacter baumannii (A. baumannii) ventilator-associated pneumonia (VAP) in intensive care unit (ICU) is associated with high morbidity and mortality in patients with critical illness. However, the literatures that focused on the short-term prognosis and the risk factors for mortality are limited. The aim of this study was to evaluate the risk factors for mortality in ICU patients with A. baumannii VAP. Methods A retrospective cohort study was conducted in the medical/surgical ICU at Zhongshan Hospital in Shanghai, China. Adult patients meeting the criteria of A. baumannii VAP from January 2012 to October 2015 were enrolled. Apart from collecting clinical and microbiologic data, we performed biofilm-formation and cytotoxicity testing using A. baumannii strains which are isolated from patients. Multivariate logistic regression analysis was used to determine the independent risk factors for 30-day mortality in ICU. Results Seventy-eight patients were included in this study. The 30-day mortality rate in ICU for the patients was 37.2%. Multivariate analysis revealed that short-term mortality was significantly associated with prior surgery [OR, 0.277; 95% confidence interval (CI), 0.089-0.866; P=0.027], higher APACHEII score (OR, 1.140; 95% CI, 1.007-1.291; P=0.038) and an increased bacterial cytotoxicity (OR, 1.029 ; 95% CI, 1.001-1.058; P=0.047). Conclusions The main finding of our study was that increased bacterial cytotoxicity might be a risk factor for short-term mortality in ICU patients with A. baumannii VAP.

[1]  A. Zlotnik,et al.  Multidrug Resistance Acinetobacter Bacteremia Secondary to Ventilator-Associated Pneumonia: Risk Factors and Outcome , 2017, Journal of intensive care medicine.

[2]  Evangelos I. Kritsotakis,et al.  Clinical epidemiology, treatment and prognostic factors of extensively drug-resistant Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients. , 2016, International journal of antimicrobial agents.

[3]  L. Martínez-Martínez,et al.  Acinetobacter baumannii and A. pittii clinical isolates lack adherence and cytotoxicity to lung epithelial cells in vitro. , 2016, Microbes and infection.

[4]  I. Cinel,et al.  Vitamin D level is associated with mortality predictors in ventilator-associated pneumonia caused by Acinetobacter baumannii. , 2016, Journal of infection in developing countries.

[5]  Y. Geffen,et al.  Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: Retrospective Comparison Between Intravenous Colistin and Intravenous Ampicillin–Sulbactam , 2016, American journal of therapeutics.

[6]  Yi Xie,et al.  Risk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West China , 2015, PloS one.

[7]  Cary L. Honnold,et al.  Fatal outbreak of an emerging clone of extensively drug-resistant Acinetobacter baumannii with enhanced virulence. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  C. Bumroongkit,et al.  Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia , 2015, Journal of Intensive Care.

[9]  P. Kaur,et al.  Incidence and attributable costs of ventilator-associated pneumonia (VAP) in a tertiary-level intensive care unit (ICU) in northern India. , 2015, Journal of infection and public health.

[10]  N. P. H. Lan,et al.  Emergence of carbapenem-resistant Acinetobacter baumannii as the major cause of ventilator-associated pneumonia in intensive care unit patients at an infectious disease hospital in southern Vietnam , 2014, Journal of medical microbiology.

[11]  Xiaochun Song,et al.  Differences in incidence and outcome of ventilator‐associated pneumonia in surgical and medical ICUs in a tertiary hospital in China , 2014, The clinical respiratory journal.

[12]  C. Bai,et al.  PcrV antibody protects multi-drug resistant Pseudomonas aeruginosa induced acute lung injury , 2014, Respiratory Physiology & Neurobiology.

[13]  A. Kaya,et al.  Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: risk factors, clinical features, and outcomes. , 2014, American journal of infection control.

[14]  A. Akin,et al.  Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia , 2014, Infection.

[15]  Qi Zhou,et al.  Efficacy of an infection control program in reducing ventilator-associated pneumonia in a Chinese neonatal intensive care unit. , 2013, American journal of infection control.

[16]  N. Shime,et al.  Evaluation of semi-quantitative scoring of Gram staining or semi-quantitative culture for the diagnosis of ventilator-associated pneumonia: a retrospective comparison with quantitative culture , 2013, Journal of Intensive Care.

[17]  Tae Hyong Kim,et al.  Risk Factors for Mortality in Patients with Acinetobacter baumannii Bacteremia , 2013, Infection & chemotherapy.

[18]  Y. Arabi,et al.  Acinetobacter is the most common pathogen associated with late-onset and recurrent ventilator-associated pneumonia in an adult intensive care unit in Saudi Arabia. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[19]  Jian-hui Chen,et al.  Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia. , 2013, American journal of infection control.

[20]  Y. Lei,et al.  Incidence and outcomes of ventilator-associated tracheobronchitis and pneumonia. , 2013, The American journal of medicine.

[21]  M. Adams,et al.  Inhibition of LpxC Protects Mice from Resistant Acinetobacter baumannii by Modulating Inflammation and Enhancing Phagocytosis , 2012, mBio.

[22]  S. Kuo,et al.  Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia. , 2012, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[23]  Yi-Tsung Lin,et al.  Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Sang Il Kim,et al.  Risk Factors for Mortality in Patients with Carbapenem-Resistant Acinetobacter baumannii Bacteremia: Impact of Appropriate Antimicrobial Therapy , 2012, Journal of Korean medical science.

[25]  M. Kollef,et al.  Economic Impact of Ventilator-Associated Pneumonia in a Large Matched Cohort , 2012, Infection Control & Hospital Epidemiology.

[26]  Eric Déziel,et al.  MexEF-OprN Efflux Pump Exports the Pseudomonas Quinolone Signal (PQS) Precursor HHQ (4-hydroxy-2-heptylquinoline) , 2011, PloS one.

[27]  M. Surette,et al.  Inactivation of MuxABC-OpmB transporter system in Pseudomonas aeruginosa leads to increased ampicillin and carbenicillin resistance and decreased virulence , 2011, The Journal of Microbiology.

[28]  J. Rello,et al.  Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study , 2011, Critical care.

[29]  J. Vila,et al.  Biofilm formation at the solid-liquid and air-liquid interfaces by Acinetobacter species , 2011, BMC Research Notes.

[30]  W. Ko,et al.  A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[31]  B. Sumerkan,et al.  Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia. , 2009, European journal of internal medicine.

[32]  D. Moranta,et al.  Klebsiella pneumoniae triggers a cytotoxic effect on airway epithelial cells , 2009, BMC Microbiology.

[33]  Chul Hee Choi,et al.  Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity , 2007, Cellular microbiology.

[34]  A. MacGowan,et al.  European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.